Viewing StudyNCT05827081



Ignite Creation Date: 2024-05-06 @ 6:53 PM
Last Modification Date: 2024-10-26 @ 2:57 PM
Study NCT ID: NCT05827081
Status: SUSPENDED
Last Update Posted: 2024-04-24
First Post: 2023-04-12

Brief Title: Phase IIIb Study of Ribociclib ET in Early Breast Cancer
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Organization Data

Organization: Novartis
Class: INDUSTRY
Study ID: CLEE011O12001
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor: Novartis Pharmaceuticals
Lead Sponsor Class: INDUSTRY
Responsible Party: None
Responsible Party Title: None
Responsible Party Type: SPONSOR
Responsible Party Affiliation: None
Old Name: None
Old Organization: None

Collaborators